FindTrial
Sign In

Inflammatory biomarker estimation in blood samples of varicose vein after repeated blood letting

Estimation of inflammatory biomarker IL-6 in blood samples of varicose veins after repeated siravyadha

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043508
Enrollment
5
Registered
2022-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I831- Varicose veins of lower extremities with inflammation Health Condition 2: I831- Varicose veins of lower extremities with inflammation

Interventions

None listed

Sponsors

Dr Anjana Sivadas
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with varicose vein, who satisfy C2 class in CEAP Classification of severity of Varicose veins Normal limits of Hemoglobin, bleeding time, clotting time

Exclusion criteria

Exclusion criteria: 1 Diagnosed cases of DVT 2 Pregnant ladies 3 Varicose ulcer 4 Person with h/o any bleeding disorders and other systemic illness • Those on medications that affect coagulation, known disorders of coagulation • Active malignancy, and comorbidity.

Design outcomes

Primary

MeasureTime frame
To check the changes in IL-6 in blood samples of varicose veins after repeated siravyadhaTimepoint: 0th day, 15th day—

Secondary

MeasureTime frame
To check the changes in IL-6 in blood samples of varicose veins after repeated siravyadhaTimepoint: 0th day, 15th day—

Countries

India

Contacts

Public ContactDrAnjana Sivadas

Amrita School of Ayurveda

kpn@ay.amrita.edu9496096694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026